{
    "2018-03-02": [
        [
            {
                "time": "",
                "original_text": "乐普医疗: 投资华世通公司, 再度布局降糖和降脂药物线重要品种",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "华世通",
                        "降糖",
                        "降脂",
                        "药物"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[增持评级] 乐普医疗(300003)：入股WATERSSTONE 制药板块锦上添花",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "WATERSSTONE",
                        "制药",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "乐普医疗：拟出售参股公司股权 增厚业绩",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "出售股权",
                        "增厚业绩"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级] 乐普医疗(300003)事件跟踪：投资WATERSSTONE 心血管药品布局持续完备",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "WATERSSTONE",
                        "心血管",
                        "药品布局"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "167股获券商买入评级 酒鬼酒目标涨幅达113.46%",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "酒鬼酒",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}